215 CHURCH STREET, NEW HAVEN, CT
Amendment No. 2 to Equity Distribution Agreement with J.P. Morgan
Reports Recent Business Developments and First Quarter 2026 Financial Results
2026 Annual Meeting Results; Directors Elected Including Michael T. Heffernan
Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
Investor Presentation
Other Events
Biohaven Ltd. Announces $200 Million Public Offering of Common Shares
Reports Third Quarter 2025 Financial Results and Recent Business Developments
Q1
FY 2025
Q3
Q2
FY 2024
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Confidential Treatment Order